Company Overview of GlycoFi, Inc.
GlycoFi, Inc. develops bio-therapeutics based on the glycan optimization technology. Its technology is based on a library of yeast strains that are engineered to perform specific human glycosylation at high fidelity. The company was incorporated in 2000 and is based in Lebanon, New Hampshire. As of June 6, 2006, GlycoFi, Inc. operates as a subsidiary of Merck & Co. Inc.
21 Lafayette Street
Lebanon, NH 03766
Founded in 2000
Key Executives for GlycoFi, Inc.
GlycoFi, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|VisiGen Biotechnologies, Inc.||United States|
|CIMA Biotechnology Inc||United States|
|Anti-Microbial Solutions, LLC||United States|
|ADS Biotechnology, Ltd.||United States|
|Proteos, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact GlycoFi, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.